A needle-free route may sound convenient, but the NAD+ nasal spray still needs product-specific evidence and instructions. Convenience does not establish effectiveness for the advertised wellness goals.
- Format
- Compounded prescription nasal spray
- Price boundary
- Advertised from $93/month
- Evidence basis
- Public catalog plus linked primary guidance
- Review date
- October 8, 2026
What the catalog describes
The current CoreAge Rx catalog offers NAD+ as a nasal spray as well as an injection. Both are associated with the Hello Energy name. This review treats the nasal preparation separately because route, formulation and administration requirements are materially different.[source]
What the evidence establishes
No independent controlled trial of this exact spray was verified in this research. Evidence involving cellular NAD+ biology, oral precursors or an injectable product cannot automatically answer whether the nasal preparation improves energy, focus or recovery.[source]
Questions for the clinical conversation
The provider describes a compounded prescription product. As FDA explains, compounded drugs are not FDA-approved and do not receive the agency’s premarket evaluation of safety, effectiveness and quality. A prescription requirement does not turn a wellness claim into an approved indication.[source]
Practical details to confirm
Ask the prescriber about the intended benefit, the evidence for the route, relevant medical history and possible adverse effects. Obtain the pharmacy’s storage and administration instructions. Do not convert an injection amount into a number of sprays or assume different preparations have equal concentrations.[source]
How to weigh this option
The published starting price is only a starting point for comparing terms. Confirm the supply period, consultation charge and follow-up. If choosing between routes, ask the clinician to explain the tradeoff with the uncertainty included, rather than using “needle-free” as the entire clinical argument.
Your questions, answered
Is this review based on using the product?
No. It is based on linked public sources. No firsthand treatment experience, clinical outcome or independent laboratory test is claimed.
Does first placement mean it is best for me?
No. CoreAge Rx is featured commercially. Your needs, the exact product and the evidence should guide a discussion with a qualified professional.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Accessed October 8, 2026.
- CoreAge Rx Help Center: current product catalogProvider formulation and consultation information
- CoreAge Rx: current advertised treatments and pricesProvider starting prices; final plan and billing terms require confirmation
- FDA — Compounding and the FDA: Questions and AnswersCompounded drugs are not FDA-approved; oversight and evidence limitations